Brian Goff, Chief Executive Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 22,898 shares at $28.36 ($649K) on 2023-06-30, disclosed to the SEC on 2023-06-30.
Scheduled sale ($649k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.36 | 11,449 | $325K | 50.0% |
| 2 | $28.36 | 11,449 | $325K | 50.0% |
| Total | $28.36 avg | 22,898 | $649K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-02 | $507K | — | Filing → |
| AGIO | SELL | 2025-08-12 | $813K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $1.3M | — | Filing → |